Suppr超能文献

由蛋白磷酸酶1α介导的正反馈环、P-TEFb的动员和基础CDK1驱动前列腺癌中的雄激素受体。

Positive feedback loop mediated by protein phosphatase 1α mobilization of P-TEFb and basal CDK1 drives androgen receptor in prostate cancer.

作者信息

Liu Xiaming, Gao Yanfei, Ye HuiHui, Gerrin Sean, Ma Fen, Wu Yiming, Zhang Tengfei, Russo Joshua, Cai Changmeng, Yuan Xin, Liu Jihong, Chen Shaoyong, Balk Steven P

机构信息

Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.

Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.

出版信息

Nucleic Acids Res. 2017 Apr 20;45(7):3738-3751. doi: 10.1093/nar/gkw1291.

Abstract

P-TEFb (CDK9/cyclin T) plays a central role in androgen receptor (AR)-mediated transactivation by phosphorylating both RNA polymerase 2 complex proteins and AR at S81. CDK9 dephosphorylation mobilizes P-TEFb from an inhibitory 7SK ribonucleoprotein complex, but mechanisms targeting phosphatases to P-TEFb are unclear. We show that AR recruits protein phosphatase 1α (PP1α), resulting in P-TEFb mobilization and CDK9-mediated AR S81 phosphorylation. This increased pS81 enhances p300 recruitment, histone acetylation, BRD4 binding and subsequent further recruitment of P-TEFb, generating a positive feedback loop that sustains transcription. AR S81 is also phosphorylated by CDK1, and blocking basal CDK1-mediated S81 phosphorylation markedly suppresses AR activity and initiation of this positive feedback loop. Finally, androgen-independent AR activity in castration-resistant prostate cancer (CRPC) cells is driven by increased CDK1-mediated S81 phosphorylation. Collectively these findings reveal a mechanism involving PP1α, CDK9 and CDK1 that is used by AR to initiate and sustain P-TEFb activity, which may be exploited to drive AR in CRPC.

摘要

周期蛋白依赖性激酶9/细胞周期蛋白T(P-TEFb)通过磷酸化RNA聚合酶II复合物蛋白和雄激素受体(AR)的第81位丝氨酸,在AR介导的反式激活中发挥核心作用。CDK9的去磷酸化可使P-TEFb从抑制性的7SK核糖核蛋白复合物中释放出来,但将磷酸酶靶向P-TEFb的机制尚不清楚。我们发现,AR招募蛋白磷酸酶1α(PP1α),导致P-TEFb释放以及CDK9介导的AR第81位丝氨酸磷酸化。这种增加的pS81增强了p300的招募、组蛋白乙酰化、BRD4结合以及随后P-TEFb的进一步招募,形成了一个维持转录的正反馈环。AR的第81位丝氨酸也被CDK1磷酸化,阻断基础CDK1介导的第81位丝氨酸磷酸化可显著抑制AR活性并启动这个正反馈环。最后,去势抵抗性前列腺癌(CRPC)细胞中不依赖雄激素的AR活性是由CDK1介导的第81位丝氨酸磷酸化增加所驱动的。这些发现共同揭示了一种涉及PP1α、CDK9和CDK1的机制,AR利用该机制启动并维持P-TEFb活性,这可能被用于驱动CRPC中的AR。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de32/5397168/c73d3e71bbbe/gkw1291fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验